Systematic review: benefits and risks of phosphodiesterase 4 inhibitors in COPD
30 Sep, 2017 | 13:21h | UTCOriginal Article: Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease – Cochrane Library (link to abstract – $ for full-text))